Dr. Reddy's Laboratories Ltd.

₹1235.15

+ 18.00 (1.48%)

04:01 pm - close price

BSE: DRREDDY

NSE: DRREDDY

Industry: Pharmaceuticals & Drugs

House: Dr. Reddy's

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 67.81Good: 5

✅

Adjusted EPS

Bad: 3Current: 67.81Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 23.25Good: 20

✅

Current Ratio

Bad: 1Current: 1.92Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 18.61Good: 15

✅

Debt to Total Assets

Bad: 1Current: 9.83Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 67.81Good: 5

✅

Adjusted EPS

Bad: 3Current: 67.81Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 23.25Good: 20

✅

Current Ratio

Bad: 1Current: 1.92Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 18.61Good: 15

✅

Debt to Total Assets

Bad: 1Current: 9.83Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	6757.90	6902.60	7236.80	7113.80	7696.10
Expenditure+	4695.80	4894.30	5213.70	5282.60	5566.20
Other Income+	174.00	315.00	216.20	197.50	187.20
Operating Profit	2062.10	2008.30	2023.10	1831.20	2129.90
Interest	37.10	35.30	39.40	59.30	59.80
Depreciation and Amortization	353.30	375.50	373.50	367.70	380.60
Profit Before Tax	1850.00	1916.70	1829.10	1605.20	1882.60
Tax+	445.00	434.50	448.20	295.40	490.20
Net Profit	1405.00	1482.20	1380.90	1309.80	1392.40

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	190475.00	215452.00	246697.00	280111.00	326439.00
Operational Expenses+	151776.00	177778.00	183207.00	200780.00	240968.00
Operating Profit	38699.00	37674.00	63490.00	79331.00	85471.00
Other Income	2914.00	4847.00	10555.00	8943.00	10973.00
OPM %	20.32	17.49	25.74	28.32	26.18
Depreciation and Amortisation	12288.00	11652.00	12502.00	14700.00	17037.00
Interest	970.00	958.00	1428.00	1711.00	2829.00
Profit Before Tax	28835.00	30614.00	60485.00	72010.00	76795.00
Tax	9319.00	8789.00	15412.00	16231.00	19543.00
Net Profit	19516.00	21825.00	45073.00	55779.00	56551.00

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	255482.00	284699.00	315799.00	378060.00	475941.00
Liabilities+	255482.00	284699.00	315799.00	378060.00	475941.00

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	35703.00	28108.00	58875.00	45433.00	46428.00
Cash from Investing Activity	-22660.00	-26387.00	-41373.00	-40283.00	-58077.00
Cash from Financing Activity	-298.00	-2422.00	-26861.00	-3763.00	18911.00
Net Cash Flow	12745.00	-701.00	-9359.00	1387.00	7262.00
Opening Cash & Cash Equivalents	1962.00	14820.00	14852.00	5779.00	7107.00
Closing Cash & Cash Equivalents	14820.00	14852.00	5779.00	7107.00	14593.00

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	26.64	26.64	26.64	26.64	26.64	26.64	26.65	26.65	26.65	26.66
Public+	62.50	62.53	62.32	61.82	60.12	59.14	58.76	58.00	58.02	59.32
Custodians	10.87	10.83	11.04	11.54	13.23	14.22	14.59	15.35	15.33	14.02
Number of Shareholders	455243	449216	451929	459605	403669	310403	267694	255500	257794	243445

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	35703.00	28108.00	58875.00	45433.00	46428.00
Cash from Investing Activity	-22660.00	-26387.00	-41373.00	-40283.00	-58077.00
Cash from Financing Activity	-298.00	-2422.00	-26861.00	-3763.00	18911.00
Net Cash Flow	12745.00	-701.00	-9359.00	1387.00	7262.00
Opening Cash & Cash Equivalents	1962.00	14820.00	14852.00	5779.00	7107.00
Closing Cash & Cash Equivalents	14820.00	14852.00	5779.00	7107.00	14593.00

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	255482.00	284699.00	315799.00	378060.00	475941.00
Liabilities+	255482.00	284699.00	315799.00	378060.00	475941.00

Ratios

Reported EPS

Bad: 2Current: 67.81Good: 5

✅

Adjusted EPS

Bad: 3Current: 67.81Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 23.25Good: 20

✅

Current Ratio

Bad: 1Current: 1.92Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 18.61Good: 15

✅

Debt to Total Assets

Bad: 1Current: 9.83Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 67.81Good: 5

✅

Adjusted EPS

Bad: 3Current: 67.81Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 23.25Good: 20

✅

Current Ratio

Bad: 1Current: 1.92Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 18.61Good: 15

✅

Debt to Total Assets

Bad: 1Current: 9.83Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	26.64	26.64	26.64	26.64	26.64	26.64	26.65	26.65	26.65	26.66
Public+	62.50	62.53	62.32	61.82	60.12	59.14	58.76	58.00	58.02	59.32
Custodians	10.87	10.83	11.04	11.54	13.23	14.22	14.59	15.35	15.33	14.02
Number of Shareholders	455243	449216	451929	459605	403669	310403	267694	255500	257794	243445

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	6757.90	6902.60	7236.80	7113.80	7696.10
Expenditure+	4695.80	4894.30	5213.70	5282.60	5566.20
Other Income+	174.00	315.00	216.20	197.50	187.20
Operating Profit	2062.10	2008.30	2023.10	1831.20	2129.90
Interest	37.10	35.30	39.40	59.30	59.80
Depreciation and Amortization	353.30	375.50	373.50	367.70	380.60
Profit Before Tax	1850.00	1916.70	1829.10	1605.20	1882.60
Tax+	445.00	434.50	448.20	295.40	490.20
Net Profit	1405.00	1482.20	1380.90	1309.80	1392.40

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	190475.00	215452.00	246697.00	280111.00	326439.00
Operational Expenses+	151776.00	177778.00	183207.00	200780.00	240968.00
Operating Profit	38699.00	37674.00	63490.00	79331.00	85471.00
Other Income	2914.00	4847.00	10555.00	8943.00	10973.00
OPM %	20.32	17.49	25.74	28.32	26.18
Depreciation and Amortisation	12288.00	11652.00	12502.00	14700.00	17037.00
Interest	970.00	958.00	1428.00	1711.00	2829.00
Profit Before Tax	28835.00	30614.00	60485.00	72010.00	76795.00
Tax	9319.00	8789.00	15412.00	16231.00	19543.00
Net Profit	19516.00	21825.00	45073.00	55779.00	56551.00

Dr. Reddy's Laboratories Ltd.

₹1235.15

+ 18.00 (1.48%)

04:01 pm - close price

BSE: DRREDDY

NSE: DRREDDY

Industry: Pharmaceuticals & Drugs

House: Dr. Reddy's

Overview